Tag Archives: breast cancer drugs
Tell the FDA: Ensure patient and consumer safety
We Can’t Be Pink’d week TWO is here and we’re calling on the Food and Drug Administration (FDA) to do better to protect patients and consumers! This week we are calling on the FDA to uphold strong standards and improve transparency to ensure drugs and medical devices are... Read more
Posted in BCA Action Alerts, BCA News, E-Alerts
SABCS 2019: T-DM1 tradeoffs: not worth the costs and side effects in early stage breast cancer
Just because there is an FDA approved treatment, should it be offered to everyone?
Dr Tolaney from the Dana Farber Cancer Institute presented data (GS1-05) exploring whether it’s appropriate to use the monoclonal antibody T-DM1 to treat early stage HER2+ breast cancer. Even... Read more
Posted in Articles
SABCS 2019: Good News and Unicorns on Day 1 of SABCS
by Karuna Jaggar, Executive Director
I feel like I saw unicorn today.
I began Day 1 of the San Antonio Breast Cancer Symposium with this tweet:
“Back for my 8th tour of breast cancer research at #SABCS19. Here’s what I’m 'still' looking for:
... Read more
Posted in Articles